With New Phase II Funding, HTG Molecular Pursues Sequencing-based RNA, DNA Quantification Approach

GenomeWeb interview with HTG's CEO, TJ Johnson, on their new Phase II Funding to pursue Sequencing-based RNA, DNA Quantification Approach.

Offsite URL:

Link to Offsite Resource